The Post-Pandemic Return of Mycoplasma pneumoniae: Why Children Matter and What Clinicians Should Know

Read full text
Authors: Takeshi Saraya
Cited by: 3
References: 53

Abstract

Mycoplasma pneumoniae infections declined sharply during COVID-19 non-pharmaceutical interventions but have resurged in multiple regions after restrictions were lifted. This narrative Perspective synthesizes recent epidemiologic and molecular observations and emphasizes children as a key reservoir sustaining community transmission. We highlight how asymptomatic carriage and prolonged upper-airway detection complicate interpretation of PCR results, and we discuss the clinical implications of macrolide-resistant M. pneumoniae (MRMP), including pragmatic, age-stratified management considerations. Finally, we outline priorities for surveillance and for translating genomic signals into simplified clinical pathways, particularly in high-MRMP settings.

Fields of Study & Subjects

Pneumonia and Respiratory Infections Respiratory viral infections research Bacterial Infections and Vaccines

Publication details

Journal / source
Journal of Clinical Medicine
Publisher
MDPI AG
Volume
15
Issue
4
Pages
1644–1644
Publication date
22 February 2026
Language
EN